Loading clinical trials...

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence | Clinical Trials | Clareo Health

COMPLETEDNA

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence (IDEA Trial)

NCT01932866•59th Medical Wing

Summary

The purpose of this randomized, controlled study is to evaluate whether the knowledge of a personalized diabetes risk score affects adherence to a 12-week diet and exercise lifestyle change program in prediabetic patients. The intervention group will receive diabetes risk score results at the beginning of the twelve weeks, and the control group will not receive these results. Both groups will review their baseline and 12-week diabetes risk score results at the conclusion of the program and will be followed for an additional twelve weeks. Attendance rates and changes in weight, BMI, abdominal circumference, blood pressure, HgA1c, fasting blood glucose, cholesterol, and diabetes risk score will be compared between the groups.

Eligibility

Age

30 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Men and women of all ethnic groups
•≥30 -75 years of age
•Pre-diabetic defined as follows: fasting plasma glucose (FPG) 100-125mg/dL, HbA1c 5.7% to 6.4%.
•Body Mass Index ≥ 25 kg/m2
•Tricare beneficiary

Exclusion Criteria

•Diagnosis of type 1 or type 2 diabetes mellitus (defined as FPG ≥126 mg/dl on two different occasions or random blood sugar ≥200) If fasting glucose \>= 126 only once, a second lab does not need to be arranged in an attempt to diagnose diabetes. It is acceptable for the patient to proceed in the trial. Also, Tethys lab results (e.g., fasting glucose and A1C) should not be used to make decisions about including or excluding patients in the trial. Only Air Force lab results should be used to make this determination.
•Active duty military members
•Patients with untreated hypothyroidism or previously diagnosed Cushing's syndrome
•Subjects previously treated with metformin or thiazolidinediones in the previous 12 months
•Psychological or physical disabilities deemed likely to interfere with participation in the study
•Patients currently using weight-loss medications or medications known to affect body weight (i.e. chronic corticosteroid use)
•Major medical conditions that prevent participation in the Group Lifestyle Balance Prevention Program (i.e. severe cardiovascular or cerebrovascular disease, severe renal or liver dysfunction, etc.)
•Concurrent participation in a different weight loss program
•Previous bariatric surgery
•Unwilling to agree with the study assignments or provide informed consent
+10 more criteria

Locations (5)

David Grant Medical Center

Travis AFB, California, United States

Andrews Military Medical Center

Andrews Air Force Base Census Designated Place, Maryland, United States

Nellis Family Medicine

Nellis Air Force Base, Nevada, United States

Wright Patterson Medical Center

Wright-Patterson AFB, Ohio, United States

Wilford Hall Ambulatory Surgical Center

Lackland Air Force Base, Texas, United States

Key Dates

Start Date

June 1, 2010

Primary Completion Date

June 1, 2013

Completion Date

June 1, 2013

Last Updated

August 30, 2013

Enrollment

223

ACTUAL participants

Conditions

Pre-diabetesDiabetes Risk ScoreMotivation

Interventions

diabetic risk score

OTHER

Mechanisms of Prediabetic States in Sleep Apnea

NCT04234217

Sleep ApneaPre-diabetes

View study

RECRUITINGNA

Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients

NCT06486012

Diabetes Mellitus, Type 2Pre-diabetes+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 30, 2013Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

Inclusion Criteria

Exclusion Criteria

Mechanisms of Prediabetic States in Sleep Apnea

Regular Use of aPDT in the Management and Prevention of Periodontitis Symptoms in Diabetic Patients

Breaking up Sedentary Time to Improve Glucose Control in a Population at Risk for Developing Type 2 Diabetes

Understanding Motivation in Parkinson's Patients Through Neurophysiology

The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

Does educatıonal Escape Game Affect Students' motıvatıon, academıc Self-effıcacy and Success Levels: a quası-experımental Study